Solventum Corp. (SOLV)
Operating return on assets (Operating ROA)
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Operating income | US$ in thousands | 1,036,000 | 1,692,000 | 1,693,000 | 1,879,000 | 1,430,000 |
Total assets | US$ in thousands | 14,457,000 | 14,377,000 | 13,594,000 | 14,075,000 | — |
Operating ROA | 7.17% | 11.77% | 12.45% | 13.35% | — |
December 31, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $1,036,000K ÷ $14,457,000K
= 7.17%
Operating ROA is a financial ratio that indicates a company's ability to generate operating profit from its assets. Solventum Corp.'s operating ROA has shown a gradual decline over the years, decreasing from 13.35% in December 31, 2021 to 7.17% in December 31, 2024. This decreasing trend suggests that the company may be facing challenges in efficiently utilizing its assets to generate operating income. It is important for Solventum Corp. to address this decline and improve its operational efficiency to enhance profitability and sustain long-term success.
Peer comparison
Dec 31, 2024
Company name
Symbol
Operating ROA
Solventum Corp.
SOLV
7.17%
3M Company
MMM
12.09%
Artivion Inc
AORT
0.72%
Baxter International Inc
BAX
1.38%
Becton Dickinson and Company
BDX
4.18%
Boston Scientific Corp
BSX
6.67%
DexCom Inc
DXCM
9.54%
Embecta Corp
EMBC
12.98%
Glaukos Corp
GKOS
-12.55%
Globus Medical
GMED
2.62%
Haemonetics Corporation
HAE
7.51%